📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells. (2018)

First Author: Goundry A

Attributed to: Proteolysis and life cycle progression in Leishmania funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201700797r

PubMed Identifier: 29097502

Publication URI: http://europepmc.org/abstract/MED/29097502

Type: Journal Article/Review

Volume: 32

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638